Literature DB >> 12846940

Approach to the Patient with Severe, Refractory Irritable Bowel Syndrome.

Kevin W. Olden1.   

Abstract

Defining which patients with irritable bowel syndrome (IBS) are "refractory" is a highly subjective undertaking. Duration of symptoms, severity of symptoms, type of symptoms, and a host of other medical, epidemiologic, and psychosocial variables all play a role in this determination. It is safe to say that a long duration of disease per se does not constitute a refractory patient. A number of studies have given us some suggestion of what constitutes refractoriness in IBS. Patients who have a predominant pain complaint as opposed to those who are mainly concerned about their bowel habit (either diarrhea or constipation) are more likely to be disabled by their IBS. However, at a clinical level, patients who are considered refractory are usually seen as individuals who fail to improve on a variety of drug therapies or who have high healthcare utilization despite aggressive treatment of their IBS. Finally, patients who are unhappy about their care and/or are assertive in their request to "be cured" can also be seen as refractory because of unrealistic expectations they set for both themselves and the physician. The key to effectively dealing with patients with "refractory" IBS is to understand that their behaviors most often have correlates and underlying issues that need to be dealt with in order to effectively address the patient's concerns. Unfortunately, most patients who fall into this category are quickly identified as "difficult," "unpleasant," or even "crazy" and are not infrequently dismissed by their treating physician. This leads to an ever-enlarging circle of healthcare utilization, with patients seeking out physicians and other practitioners looking for the elusive cure. A key component of this process is an increasing frustration and cynicism regarding the healthcare system and physicians in particular, which does no good for anyone involved. It is clearly critical for the physician dealing with a patient with IBS and a history of poor response to treatment to understand these correlates. Failure to do so creates a continuation of the cycle of treatment failure and frustration that so often characterizes these patients' care.

Entities:  

Year:  2003        PMID: 12846940     DOI: 10.1007/s11938-003-0023-8

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  8 in total

Review 1.  Psychologic and psychiatric aspects of gastrointestinal disease.

Authors:  K W Olden; D A Drossman
Journal:  Med Clin North Am       Date:  2000-09       Impact factor: 5.456

2.  Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis.

Authors:  J L Jackson; P G O'Malley; G Tomkins; E Balden; J Santoro; K Kroenke
Journal:  Am J Med       Date:  2000-01       Impact factor: 4.965

3.  Impact of sexual and physical abuse dimensions on health status: development of an abuse severity measure.

Authors:  J Leserman; Z Li; D A Drossman; T C Toomey; G Nachman; L Glogau
Journal:  Psychosom Med       Date:  1997 Mar-Apr       Impact factor: 4.312

4.  Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications.

Authors:  A D Sperber; Y Atzmon; L Neumann; I Weisberg; Y Shalit; M Abu-Shakrah; A Fich; D Buskila
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

5.  The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

Authors:  Francis Creed; Lakshmi Fernandes; Elspeth Guthrie; Stephen Palmer; Joy Ratcliffe; Nicholas Read; Christine Rigby; David Thompson; Barbara Tomenson
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

Review 6.  Sexual and physical abuse and gastrointestinal illness. Review and recommendations.

Authors:  D A Drossman; N J Talley; J Leserman; K W Olden; M A Barreiro
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

7.  Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples.

Authors:  W E Whitehead; L Bosmajian; A B Zonderman; P T Costa; M M Schuster
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

8.  Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

Authors:  D A Drossman; D C McKee; R S Sandler; C M Mitchell; E M Cramer; B C Lowman; A L Burger
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

  8 in total
  4 in total

1.  The structure of resilience in irritable bowel syndrome and its improvement through hypnotherapy: Cross-sectional and prospective longitudinal data.

Authors:  Johannes Peter; Ulrich S Tran; Maria Michalski; Gabriele Moser
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

2.  Patients' perspectives on GP interactions after cognitive behavioural therapy for refractory IBS: a qualitative study in UK primary and secondary care.

Authors:  Alice Sibelli; Rona Moss-Morris; Trudie Chalder; Felicity L Bishop; Sula Windgassen; Hazel Everitt
Journal:  Br J Gen Pract       Date:  2018-07-30       Impact factor: 5.386

3.  Irritable Bowel Syndrome in a Population of a Developing Country: Prevalence and Association.

Authors:  Abdul Latif; Farooque Aziz Memon; Mansoor Asad
Journal:  Cureus       Date:  2020-05-14

4.  Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis.

Authors:  Christopher Ma; Stephen E Congly; Kerri L Novak; Paul J Belletrutti; Maitreyi Raman; Matthew Woo; Christopher N Andrews; Yasmin Nasser
Journal:  Gastroenterology       Date:  2020-10-01       Impact factor: 22.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.